PDL BioPharma, Inc. Book Value per Share Growth

Book Value per Share Growth of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Book Value per Share Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Book Value per Share Growth for the quarter ending June 29, 2020 was -35.59% (a 116.35% increase compared to previous quarter)
  • Year-over-year quarterly Book Value per Share Growth decreased by -485.17%
  • Annual Book Value per Share Growth for 2019 was -0.18% (a -97.74% decrease from previous year)
  • Annual Book Value per Share Growth for 2018 was -7.97% (a -144.18% decrease from previous year)
  • Annual Book Value per Share Growth for 2017 was 18.04% (a 118.14% increase from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Book Value per Share Growth of PDL BioPharma, Inc.

Most recent Book Value per Share Growthof PDLI including historical data for past 10 years.

Interactive Chart of Book Value per Share Growth of PDL BioPharma, Inc.

PDL BioPharma, Inc. Book Value per Share Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 -35.59% -16.45%
2019 -0.18% 9.24% 15.98% -3.22% -0.18%
2018 -7.97% -5.15% -7.79% 19.46% -7.97%
2017 18.04% 18.35% 16.65% 2.72% 18.04%
2016 8.27% 26.26% 39.89% 63.42% 8.27%
2015 46.38% 45.27% 74.14% 107.54% 46.38%
2014 258.55% 563.22% 20668.89% 299.61% 258.55%
2013 266.45% 145.75% 99.22% 61.61% 266.45%
2012 66.66% 52.53% 45.12% 34.35% 66.66%
2011 42.89% 27.11% 42.23% 36.59% 42.89%
2010 33.29% -7.6% -41.35% 33.29%

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.